Immunobiology

Papers
(The H4-Index of Immunobiology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Novel evaluation indicators of MOG35∼55 induced experimental autoimmune encephalomyelitis in C57BL/6J mice55
Opportunistic pneumonia caused by E. cuniculi in mice immunosuppressed with cyclophosphamide43
130 Low Gene Copy Numbers (GCN) of complement C4 and C4A deficiency are highly significant genetic risk factors for idiopathic inflammatory myopathies and its major subgroups36
230 Interaction of factor H and factor H-related proteins with S and N proteins of SARS-CoV-231
164 Role of nutraceuticals in ameliorating inflammation in Alzheimer[StQuote]s disease30
147 Antibodies against Streptococcus pneumoniae pneumolysin correlate with modified HDL levels and complement activation markers in peripheral arterial disease patients27
242 Does C1q modulate myelin sheath development in zebrafish?25
LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis24
Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice24
Decreased number of myeloid-derived suppressor cells in the placental trophoblast of gestational diabetes mellitus. Possible role of leptin23
NK-92 cells change their phenotype and function when cocultured with IL-15, IL-18 and trophoblast cells23
Reduced susceptibility to COVID-19 associated with ABO blood group and pre-existing anti-A and anti-B antibodies22
Antipyretic and anti-inflammatory effects of inosine, an active component of Kangfuxin22
The predictive value of miR-377 and phospholipase A2 in the early diagnosis of diabetic kidney disease and their relationship with inflammatory factors20
Maternal stress increases risk of allergic lung inflammation in adult mice19
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis19
51 Activation of complement in a mouse model of severe COVID-1918
221 SYNERGY-1: A Phase 1, first-in-human, randomized, double-blind, placebo-controlled safety, tolerability, immunogenicity, PK and PD study of KP104 in escalating single and multiple doses18
0.19165992736816